Prestige Biologics Co., Ltd. (KOSDAQ:334970)

South Korea · Delayed Price · Currency is KRW

3,235.00

+15.00 (0.47%)

At close: Dec 5, 2025

Revenue by Product

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019
Antibody Drugs	1.48B	Log In	Log In	Log In
Antibody Drugs Growth	-53.24%	Log In	Log In	Log In
Other than Service	689.62M	Log In	Log In	Log In
Other than Service Growth	132.37%	Log In	Log In	Log In
Daily Medicine	-	Log In	Log In	Log In
Daily Medicine Growth	-	Log In	Log In	Log In

Revenue by Geography

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019
South Korea	2.17B	Log In	Log In	Log In
South Korea Growth	-37.32%	Log In	Log In	Log In